new clearer travel system: red list and rest of world
simpler, cheaper rules for fully vaccinated travellers coming from non-red list countries – fully vaccinated passengers will be able to replace day 2 PCR tests with cheaper lateral flow tests – from the end of October – and no longer need to take pre-departure tests (PDTs)
8 destinations removed from red list including Turkey and Pakistan
government recognises full vaccinations from a further 17 countries and territories including Japan and Singapore
The Transport Secretary, Grant Shapps, has announced a simplified system for international travel in light of the success of the UK’s domestic vaccine rollout, providing greater stability for industry and passengers.
The current traffic light system will be replaced by a single red list of countries and territories which will continue to be crucial in order to protect public health, and simplified travel measures for arrivals from the rest of the world from Monday 4 October at 4am.
Testing requirements will also be reduced for eligible fully vaccinated travellers, who will no longer need to take a PDT when travelling to England from Monday 4 October 4am.
From the end of October, eligible fully vaccinated passengers and those with an approved vaccine from a select group of non-red countries will be able to replace their day 2 test with a cheaper lateral flow test, reducing the cost of tests on arrival into England. The government wants to introduce this by the end of October, aiming to have it in place for when people return from half-term breaks.
Anyone testing positive will need to isolate and take a confirmatory PCR test, at no additional cost to the traveller, which would be genomically sequenced to help identify new variants.
Testing for unvaccinated passengers from non-red countries will include pre-departure tests, day 2 and day 8 PCR tests. Test to release remains an option to reduce self-isolation period.
From 4 October, England will welcome fully vaccinated travellers from a host of new countries – who will be treated like returning fully vaccinated UK travellers – including 17 countries and territories such as Japan and Singapore, following the success of an existing pilot with the US and Europe.
Grant Shapps Transport Secretary said: “Today’s changes mean a simpler, more straightforward system. One with less testing and lower costs, allowing more people to travel, see loved ones or conduct business around the world while providing a boost for the travel industry.
“Public health has always been at the heart of our international travel policy and with more than 8 in 10 adults vaccinated in the UK, we are now able to introduce a proportionate updated structure that reflects the new landscape.”
Part of the third Global Travel Taskforce checkpoint review, today’s update reiterates the government’s focus on protecting its borders from the most dangerous variants and ensures continuity for industry and passengers the remainder of the year. We will look to set out a further review for the UK’s international travel policy early in the new year to provide further certainty for the spring and summer 2022 seasons.
Conducting the final regular traffic light review before the switch to the new two-tiered system, several additional countries and territories will move off the red list – Turkey, Pakistan, the Maldives, Egypt, Sri Lanka, Oman, Bangladesh and Kenya. Changes will come into effect at 4am Wednesday 22 September.
Passengers who aren’t recognised as being fully vaccinated with authorised vaccines and certificates under England’s international travel rules, will still have to take a pre-departure test, a day 2 and day 8 PCR test and self-isolate for 10 days upon their return from a non-red list country under the new two-tiered travel programme.
Test to Release will remain an option for unvaccinated passengers who wish to shorten their isolation period.
Sajid Javid, Health and Social Care Secretary, said: Today we have simplified the travel rules to make them easier to understand and follow, opening up tourism and reducing the costs to go abroad.
“As global vaccination efforts continue to accelerate and more people gain protection from this dreadful disease, it is right that our rules and regulations keep pace.”
From late October, we will also be making changes to allow passengers who change flights or international trains during their journey to follow the measures associated to their country of departure, rather than any countries they have transited through as part of their journey.
Passengers should continue to check GOV.UK travel guidance including FCDO travel advice before, during and after travel to keep up to date in entry requirements and ensure compliance with the latest COVID-19 and non-COVID-19 regulations for the country being visited.
These new arrangements apply to England only. The UK Government decision to implement proposals to remove the requirement for a pre-departure test in England and to use lateral flow tests on day two have not been adopted at this stage in Scotland due to significant concerns at the impact on public health.
The testing of international travellers, both before and after travel, is an important part of Scotland’s border health surveillance to minimise the risk of importing variants of concern.
The Scottish Government aims to maintain a four nations approach to international travel restrictions, but will need to carefully consider the risks associated with aligning with the UK Government.
Cabinet Secretary for Net Zero, Energy and Transport Michael Matheson said the simplification of the system recognises the success of global vaccination programmes.
He said: “This is a major step but one with sensible safeguards built in recognising the success of the Scottish Government’s vaccination programme.
“The expansion of the eligible vaccinated traveller policy combined with the changes to the traffic light system will provide a welcome boost to Scotland’s tourism industry.
“However, we have concerns that the UK Government’s proposals to remove the requirement for a pre-departure test for some travellers will weaken our ability to protect the public health of Scotland’s communities. While we want to maintain a four nations approach to these matters, we need to consider urgently their implications.”
People are now able to use private sector tests where they are now required when returning to Scotland. The step allows people to choose from a list of approved providers which can be found on the gov.uk website.
Countries removed from the red list from 4 am on 22 September are:
Bangladesh
Egypt
Kenya
Maldives
Oman
Pakistan
Sri Lanka
Turkey
Countries added to the eligible vaccinated traveller policy from 4 October are:
Canada
Australia
Israel
New Zealand
Singapore
Antigua & Barbuda
Barbados
Brunei
Taiwan
Dominica
Japan
South Korea
Qatar
Kuwait
Malaysia
Saudi Arabia
Bahrain
Following a review, the existing travel regulations have been consolidated, with minor amendments, into a single instrument. The Health Protection (Coronavirus) (International Travel and Operator Liability) (Scotland) Regulations 2021 come into force on Monday 20 September, replacing the existing regulations. Policy and requirements on travellers remain the same through this change.
A strategy to deliver world class cancer care for children and young people has been published by the Scottish Government.
Collaborative and Compassionate Cancer Care, the Cancer Strategy for Children and Young People in Scotland 2021-2026, was launched by Health Secretary Humza Yousaf during an online event yesterday.
The strategy highlights 10 priorities for the next five years, supported by almost £6 million investment, which include:
working towards funding genetic testing to provide personally targeted treatment
expanding Chimeric Antigen Receptor T-Cell therapy (CAR-T) to teenagers and young adults
setting up a national molecular radiotherapy service for children
funding a dedicated health workforce to care for teenagers and young adults
raising the profile of supported care services and holistic care
developing a single centre of excellence to provide radiotherapy treatment to improve survival among children with cancer
Mr Yousaf said: “Receiving a cancer diagnosis is never easy, but receiving one at such a young age is especially difficult.
“We know that diagnosis has come a long way, with survival rates remaining stable for children and young people. However there is still more we can do to support this age group to live long, healthy and happy lives.
“This strategy, backed by almost £6 million, marks an exciting time for children and young people’s cancer services as the first strategy for this age group. It outlines our 10 ambitions to build on previous successes so that, by 2026, we will see improved and enhanced outcomes for patients and ensure equal access to care across Scotland.”
Medical Director of NHS Forth Valley Andrew Murray said: “I am delighted to see the launch of Collaborative and Compassionate Cancer Care, after such a challenging period in the NHS Scotland’s history, and I look forward to working with our clinicians and families to deliver its ambitious objectives over the next five years, improving experiences and outcomes.”
The launch was somewhat overshadowed by news that the Scottish Government is calling in the army to help tackle a crisis in the ambulance service – and a Twitter post of a film of Health Minister Humza Yousaf’s unfortunate accident on a scooter.
City of Edinburgh Council finance leaders have welcomed yesterday’s Scottish Government announcement that around 8,000 Edinburgh children from low-income families will benefit from a £320 uplift before Christmas.
This follows three payments that were made late in 2020 and early this year to eligible families by the Council, taking the total to £620 received by each child.
In Edinburgh, these were:
a Winter Support Fund payment of £100 per child in December 2020;
a Spring Hardship Payment of £100 per child in March 2021; and
a Summer Family Pandemic Payment of £100 per child in June 2021. This was issued along with the Summer holiday Free School Meals Payment of £92.50 per child.
This will take the total money distributed to children in low-income families by the end of 2021, over these five payments, to around £4.8 million.
In 2022, the Council also will deliver £520 payments per child in 4 instalments on behalf of the Scottish Government.
As detailed by the Scottish Government, this cash is equivalent to the Scottish Child Payment (SCP), a £10-a-week benefit which provides regular, additional financial support for families in receipt of qualifying benefits to assist with the costs of caring for a child aged under six years old.
Finance Convener Councillor Rob Munn said: “Many families are still feeling the effects of the pandemic and it’s more important than ever that we continue to support those most in need, particularly at a time of year when household bills are increasing. So we welcome this additional money from the Scottish Government, that will be administered through the Council, to give some added relief.
“As a Council we are committed to ending poverty and supporting the wellbeing of our residents and through building a better foundation for our young people we hope that we can create a better future for all.”
Finance Vice Convener Councillor Joan Griffiths said:“Direct support must go hand in hand with the ongoing financial support to ensure that no child is left behind as a result of these unprecedented times.
“Our teams from across Children’s Services have worked tirelessly to put in place a series of measures across the city to continue to support and monitor the effects the pandemic is having on our children. Thanks must go to all our hard-working staff and third sector partners who are providing these vital services.”
New guidance will allow care home residents to choose a friend or relative as a ‘named visitor’ who will be able to visit them, even during a managed Covid-19 outbreak.
This is a change to current practice where most homes suspend routine visiting until outbreaks are over. It will allow those living in care homes to continue to have meaningful contact with loved ones, and balance the need for continuing infection prevention and control measures in care homes with the wider wellbeing of residents.
The change will apply to one named visitor when a care home is in a controlled Covid-19 outbreak, and a guidance note has been issued to support care homes to plan for this in consultation with their local Health Protection team.
Revised guidance from Public Health Scotland issued last week has already set out that residents should be able to receive visits from a nominated person even while they are self-isolating as a precaution (i.e. after hospital stays; after being close contacts of a COVID-19 case if fully vaccinated).
Meanwhile Social Care Minister Kevin Stewart has reaffirmed the government’s commitment to introducing ‘Anne’s Law’, to enable people who live in care homes to choose a person or persons to support them in their health and wellbeing, as called for by Care Home Relatives Scotland. A consultation on how best to implement this will be published shortly.
Minister for Mental Wellbeing and Social Care Kevin Stewart said: “Throughout the pandemic, our overriding priority in care homes has been to safeguard and protect staff and residents from infection – but at times that meant that residents were cut off from their loved ones, which we know has caused anguish and distress for many.
“The proposal for a named visitor will provide continuity of meaningful contact for care home residents in managed COVID-19 outbreak situations, helping to protect residents’ wellbeing in parallel by allowing visiting in a safer way, rather than automatically suspending routine visiting during an outbreak.
“We will further strengthen residents’ rights in adult residential settings through the introduction of ‘Anne’s Law’ and a consultation setting out our aspirations for Anne’s Law and seeking views on how best we might make it work in practice will be published shortly.”
Around 148,000 children set to benefit from £320 uplift before Christmas
Low income families will benefit from a £320 uplift before Christmas as part of the Scottish Government’s commitment to tackling child poverty.
Eligible families with children in school will receive payments of £160 per child in October and December. Two Bridging Payments of £100 have already been made via local councils, taking the total to £520 this year.
The cash is equivalent to the Scottish Child Payment (SCP), a £10-a-week benefit which provides regular, additional financial support for families in receipt of qualifying benefits to assist with the costs of caring for a child aged under six years old.
SCP will be extended to all eligible under-16s by the end of 2022, with quarterly Bridging Payments made in the interim. The Scottish Government also intends to double the SCP to £20 per week as quickly as possible following the expansion.
Social Justice Secretary Shona Robison will highlight the payments today when she opens a parliamentary debate on the commitments in the Programme for Government which aim to create a fairer society.
She said: “We are determined to build a better future for Scotland’s children and we know how important these payments will be to families in need this winter – particularly with rising fuel bills and Christmas just around the corner.
“Together the Scottish Child Payment and Bridging Payments will put an estimated £130 million in the pockets of low income families this year, providing support as we recover from the pandemic.
“Scottish Child Payment is already the most ambitious anti-poverty measure currently being undertaken anywhere in the UK and we have committed to doubling it to £20-a-week per child as soon as possible in this parliamentary term.
“It stands in stark contrast to the indefensible move by the UK Government to withdraw £20-a-week in Universal Credit from those who need it most.”
Councillor Gail Macgregor, COSLA’s Resources spokesperson, said: “Councils are pleased to be able to ensure that eligible low income families have access to an additional £520 this year and next through these Bridging Payments.
“It is important families who have been hardest hit by the pandemic have these vital additional funds as we move forward with the challenging recovery process.
“This demonstrates how local government can reach in and support families in our communities.”
Satwat Rehman, CEO of One Parent Families Scotland, said: “The SCP Bridging Payments have been a welcome support to many single parent families supported by One Parent Families Scotland, many of whom are struggling to make choices between heating their homes and feeding their children and themselves.
“These payments send a message to families that the Scottish Government is aware of their challenges and is actively trying to address them.
“With fuel prices due to rise with by an average 12%, single parent families remain at risk of falling deeper into poverty and debt in Scotland. More than ever, One Parent Families Scotland believes that regular, predictable, adequate income should be at the heart of tackling child poverty and achieving the national mission to end child poverty.”
Support for children and young people with mental health issues
Funding of £10.83 million has been allocated for the remainder of this year to help improve access to Child and Adolescent Mental Health Services (CAMHS).
The investment will also increase the numbers of trained professionals to support children and young people with neurodevelopmental support needs.
The allocation is part the of £120 million Mental Health Recovery and Renewal Fund announced in February 2021, and will help to deliver a number of improvements, including: · improve access to CAMHS assessments out of hours · help to put in place specialist regional CAMHS services including those with learning disabilities and those requiring secure care · Help provide access to CAMHS Intensive Home Treatment Teams · Support mental health liaison teams within paediatric services.
The Recovery and Renewal Fund supports many mental health measures contained in the Programme for Government.
Other policies include extra support for health and care staff, completion of the commitment to recruit 800 additional mental health workers this year and a pledge that at least 10% of frontline NHS spending will go towards mental health over this parliament.
Mental Wellbeing and Social Care Minister Kevin Stewart, who announced the allocation during a visit to the Young People’s Inpatient Unit at The Royal Hospital for Children and Young People Edinburgh said: “I am pleased to announce the allocation of £10.83 million health boards to support children and young people with mental health issues, and those with neurodevelopmental support needs.
“This funding will lead to substantial improvements in the mental health care that children and young people receive in Scotland, ensuring that the right support is available in the right place at the right time.
“We know the pandemic has had a negative impact on many people’s mental health – whatever their age or circumstances. That is why we committed £120 million to the recovery and renewal of mental health services in this year’s Programme for Government. I hope that the allocation I have announced today makes a real and lasting difference to children, young people and their families.”
Joanna Barrett, Associate Head of Policy for the Devolved Nations, NSPCC Scotland, said: “Before the pandemic hit, thousands of children referred to mental health services in Scotland were having to wait unacceptable periods of time for treatment to begin.
“The profound impact of the conditions of the past 18 months on children has compounded this by increasing the need. Our Childline counsellors have heard from children struggling with loneliness and isolation, worries about education, abusive home environments and suicidal feelings.
“This funding by the Scottish Government to address young people’s mental health is therefore crucial. However, this investment must go alongside more preventative efforts, including the provision of mental health support in schools, to ensure children get the help they need before reaching crisis point.”
Children and young people aged 12 -15 years old will be offered a dose of the coronavirus (COVID-19) vaccination from Monday (20 September) after Scottish Ministers accepted advice from the four UK Chief Medical Officers (CMOs).
As a result, a dose of Pfizer-BioNTech vaccine will be offered to all children and young people aged 12-15 who are not already covered by existing advice from the Joint Committee on Vaccination and Immunisation (JCVI) in a move to reduce the disruption caused to education by COVID-19.
This group will be offered their injections in drop-in clinics and community settings followed by each young person receiving a letter inviting them to attend a community clinic.
For some rural Health Boards, those aged 12 to 15 will first be offered the vaccine at school.
Following the initial phase, vaccines will be offered in both communities and schools so that anyone who hasn’t been vaccinated but would like to be has the opportunity to take up the offer.
Meanwhile, people who received their vaccination during phase one of the national COVID-19 vaccination programme in Scotland will start to receive booster injections from 20 September.
This follows advice from the JCVI which has advised that the booster dose can be given alongside the flu jab and should be offered no earlier than six months after completion of the primary vaccine course.
Frontline health and social care workers will be able to book their appointment online at NHS Inform from 20 September and from that date, residents in care homes for older people will be offered both flu and COVID-19 booster vaccination.
Adults aged 70 years and over and adults aged 16 years and over who are on the highest risk list (previously known as the shielding list) will be contacted soon, either by letter or by their GP.
People on the highest risk list who were severely immunosuppressed at the time of their last COVID-19 vaccination will be offered a third primary dose instead. Other eligible groups – including all those aged 16 to 49 years with underlying health conditions, adult carers, unpaid and young carers, adult household contacts of immunosuppressed individuals and all adults over 50 – will be able to book online from October.
Health Secretary Humza Yousaf said: “I want to thank Dr Gregor Smith and the other three UK CMOs who have taken the time to consider the benefits of offering a first dose of the COVID-19 vaccination to 12-15 year olds.
“I recognise the impact disruption to education can have and am keen that we do all we can to reduce this so I am happy to accept the recommendation to proceed.
“As the CMOs recommended, informed consent must be at the heart of decision making so we will ensure that there is clear communication with this age group and their parents so they understand the potential benefits, potential side effects and the balance between them.
“A new leaflet from Public Health Scotland will be circulated to ensure parents, carers and young people have all the information they need. Individual choice is central to this, and the decisions of parents, carers and children will be respected.
“Alongside the booster programme this will be a busy period for our largest ever vaccination programme but work has been underway for some time to plan for this and I am confident our roll-out will continue to be a huge success.”
Statement given by the First Minister Nicola Sturgeon to the Scottish Parliament on Tuesday 14 September 2021
Thanks, Presiding Officer,
I will give an update today on the latest COVID situation.
I can confirm that the Cabinet met this morning, and decided not to make any immediate changes to the current regulations in place.
I will also give an update on certain other issues, most notably the mitigations in place for schools, including of course our approach to vaccination of 12 to 15 year olds, and the issue of a vaccine booster programme, which we have received final JVCI advice on this morning.
Firstly, though, to recap on today’s statistics.
3,375 positive cases were reported yesterday – 11.4% of all tests.
1,064 people are currently in hospital with COVID – 16 more than yesterday.
And 89 people are receiving intensive care – that is one fewer than yesterday.
Sadly, a further 21 deaths have been reported in the past 24 hours, and the total number of deaths under the daily definition is now 8,263.
And, as always, I send my condolences to everyone who has lost a loved one.
Good progress continues to be made in the vaccination programme.
As of this morning, 4,144,904 people have had a first dose and 3,788,551 have now had both doses.
95% of people over 40 are fully vaccinated with two doses now, as are 73% of 30-39 year olds, and 60% of 18 to 29 year olds.
Around 76% of 18-29 year olds have, though, had a first dose, so the proportion in that age group who become fully vaccinated will continue to increase in the weeks ahead.
In addition, 65% of 16 and 17 year olds have now had the first jag – which is five percentage points higher than at this time last week.
Presiding Officer,
Although the level of infection in Scotland remains too high, there are continuing signs that the recent spike in cases is now slowing down.
Indeed, we are now seeing early signs – not just that the rate of increase is slowing – but that cases are now actually starting to fall slightly.
This can be seen in the last three weeks’ data
In the week to 28 August, there were an average of 5,651 new cases a day – which was an increase of more than 80% on the previous week.
In the week to 4 September, average daily cases were 6,290 – still an increase, but one of just 11%.
However, in the seven days to 11 September – so the most recent seven-day period – cases have fallen to an average of 5,506 per day – which is 12% lower than last week.
It might also be worth providing some detail on the age breakdown of cases.
In the past week, more than 70% of cases have been in the under 45s.
And that’s consistent with the pattern we’ve seen throughout this latest wave.
However, the picture varies across different age groups – that said, there are broadly positive signs now in all of them.
Two weeks ago – in the week to 4 September – the number of cases in the 0-14 year old band rose by 51%. However in the past week, cases in that age group have fallen by 5%.
Amongst 15-24 year olds, cases fell by 16% two weeks ago, and have now fallen even further – by 34% – in the most recent week.
Two weeks ago, cases in the 25-44 year old age group rose by 7%, and last week, they fell by 14%.
Finally, the number of cases amongst the over 65s has risen slightly, but again the rate of increase has slowed down over the past week.
This most recent data underpinned Cabinet’s decision earlier today not to reintroduce any restrictions.
I am very grateful to everyone – organisations, businesses and individuals – who has taken extra care in recent weeks to try to stop this spike.
It does seem that these efforts are making a difference.
That said, of course, our position does remain challenging.
Even though new cases have fallen, they remain five times higher than at the start of August.
Universities are now returning for a new term. That is very welcome – but it also creates some additional risk, and I will say more shortly about how we are working to mitigate that risk.
Overall, though, the key point is this – the recent fall in cases is very welcome, but we cannot take it for granted. We must continue efforts to keep cases on a downward track.
The NHS is already under considerable pressure and any further rise in cases would intensify that.
As we know, vaccination has significantly weakened the link between cases of COVID and serious health harm from COVID.
The proportion of people with the virus who end up in hospital remains much lower now than before the vaccine programme started.
But current case numbers reflect how transmissible the Delta variant is.
So as we can see already – even a lower percentage of a large number of cases results in a high number of hospitalisations.
To illustrate that, on 20 August, there were 312 people in hospital with COVID. Today, there are 1,064.
The number in intensive care has also increased – from 34 on 20 August to 89 today.
Of course, these figures do not include people who don’t need hospital care, but nevertheless suffer long COVID.
It is also important to remember that the pressure that the NHS is experiencing falls on staff who have in many cases been working flat-out since the start of this pandemic.
And it comes at a time when the NHS is working to catch up on a backlog and care for everyone who needs it, not just COVID patients.
The Government continues to work closely with health boards to help manage these pressures.
But – as has been the case throughout the pandemic – everyone has a role to play.
At the start of the pandemic, we constantly emphasised the need to “protect our NHS”.
That is still necessary, and should give all of us even more incentive to get vaccinated, test regularly, and take all the basic precautions that we know can slow down transmission.
An additional reason for continued caution is that it helps protect those most at risk.
The UK Government announced earlier today that it will no longer use its Shielding Patient List.
In light of that – and to avoid any mistaken assumption – it’s important for us to confirm that the Scottish Government is not following suit at this stage. We will continue to use our equivalent list – which is the Highest Risk List.
We have used this throughout the pandemic to communicate with all those at highest risk and ensure that they have advice and support.
We will continue to keep this under review, but for the moment we believe it is important to retain it.
I will now provide a brief update on some specific strands of work.
Firstly, I can confirm that Cabinet Secretaries are continuing to engage with representatives from business, the public sector and wider civic society to encourage maximum compliance with the mitigations still in place.
I will be taking part in a roundtable meeting with a range of stakeholders immediately after this statement to underline the importance of this work.
I am, again, grateful to all businesses and organisations for the efforts being made to follow and promote measures like the wearing of face coverings; good ventilation and hygiene; and wherever possible, continued home working.
In addition, as I mentioned earlier the university term is now starting – colleges began their return a few weeks ago. And we have been working closely with universities, colleges and the wider sector to make the return as safe as possible.
As a precaution at this stage, colleges and universities won’t be holding large in-person lectures for now.
Instead, there will be a mix of online and in-person learning – with institutions themselves deciding the level of in-person teaching that they will offer during this term.
In addition, physical distancing will remain in place on campuses and face coverings will be required in indoor public spaces.
We are also – of course – encouraging students to get tested regularly. Test kits are available on campuses, and students who are moving to term-time accommodation should book a PCR test before making that move.
Above all, we are strongly encouraging students to get vaccinated if they haven’t done so already.
Mobile vaccination units are being deployed in universities and colleges during freshers’ weeks, and vaccination will continue to be made available throughout the term.
Health Board web pages will contain details of local drop-in clinics and also clinics operating within colleges or universities.
We are also continuing to work with local authorities to make schools and childcare centres as safe as possible – for example, though support for the use of carbon dioxide monitors and improved ventilation.
We have also received further advice from the Advisory sub-group on Education, and I want to take the opportunity today to highlight two points arising from that advice.
First, we indicated at the start of term that secondary schools pupils would need to wear face coverings in class for the first six weeks of term, subject to a review at that point.
Given the continuing high levels of infection still being experienced at this stage, the Advisory sub-group has advised that this requirement should remain in place until the October holidays, and be reviewed again then.
I know how unpopular this is with many pupils and I completely understand why.
But for now, it remains a prudent and a necessary precaution.
Second, we intend to clarify an aspect of guidance on contact tracing in schools, to help ensure fuller understanding of the process.
There is no change in advice for close contacts thought to be at high risk of having COVID. They will continue to be advised to self-isolate until they have returned a negative PCR test. For children and young people, a high-risk contact is most likely to be a household member, or someone they have stayed overnight with.
However, we will clarify guidance on the letters that schools send to lower-risk contacts. These letters should be sent on a targeted basis to those who are most likely to have had low risk contact with someone who has tested positive. They ensure that parents, staff and pupils are aware of those cases – and the letters offer advice on issues like looking out for symptoms, and using lateral flow testing.
Our updated guidance may mean, for example, that it is appropriate to send letters to the classmates of a pupil who has tested positive, but not necessarily to everyone in their year group.
We hope that better targeting will help reinforce the importance of the messages in these letters while minimising undue anxiety.
In addition, the advice in the letters will be strengthened in one respect.
They will recommend – to primary and secondary school pupils and staff who receive them – that a lateral flow test is taken before they next return to school. That test should be in addition to the regular twice weekly lateral flow testing which is recommended for all secondary school pupils and staff.
Presiding Officer,
All of these measures reflect our commitment to prioritising the wellbeing of children and young people – and our determination to minimise disruption to education.
That consideration was also, of course, central to the advice that the Scottish, Welsh, and UK Governments – and the Northern Irish Executive – received yesterday from our Chief Medical Officers.
Members will recall that the JCVI had concluded that the benefit of vaccination – the health benefit – for 12-15 year olds did outweigh any risks, but that because this was marginal they could not recommend a universal offer of vaccine to this age group on health grounds alone.
However, they indicated that it would be appropriate for Chief Medical Officers to consider whether any wider issues might tip the balance in the other direction.
The CMOs have now done so and concluded that vaccination could reduce disruption to education and that, taken together with the health benefits previously identified in the JCVI advice, extending the offer of vaccination to all 12 to 15 year olds is justified.
Taking this broader view of the benefits and risks of vaccination, the CMOs are recommending that 12 to 15 year olds should be offered one dose of the Pfizer vaccine.
This advice has been broadly endorsed by the Royal College of Paediatrics and Child Health.
I am very grateful to all of the four Chief Medical Officers for assessing the evidence on this issue with such pace and also with such rigour.
I can confirm to Parliament today that the Scottish Government welcomes and accepts this recommendation. We believe that vaccination of 12-15 year olds is important and we will therefore move to implement the advice as quickly as possible.
Our supplies of vaccine are adequate to allow us to do this.
It is, of course, important to stress how important informed consent is.
I know that many young people and their parents will have questions.
Material will be made available online later this week.
It will be appropriate to both young people and adults. It will seek to answer questions and provide balanced information to help young people and their parents make informed choices.
And I can confirm that from Monday 20 September, so Monday coming, drop in clinics will be open for any 12 – 15 year old who has read the information and – in discussion with parents and carers – decided that they do wish to be vaccinated.
It will of course be appropriate for parents or carers to accompany their children to clinics, and vaccinators will be on hand to answer any further questions or address any concerns.
And then, starting in the following week – so week beginning 27 September – letters will be sent to all 12 to 15 year olds inviting them to an appointment at a drop-in centre or vaccination clinic.
Again, parents and carers will be invited to accompany their children. And again the appointment will include an opportunity to ask questions and discuss concerns.
Finally, after the scheduled community sessions, there will be a programme of vaccination in schools, to ensure that anyone who hasn’t been vaccinated, and who decides that they want to be, gets a further opportunity.
Presiding Officer,
I know that these are important decisions for young people and their parents, and that many will have questions. I would encourage everyone to read the information that will be provided, and do not hesitate to visit a drop in clinic to ask any questions or raise any concerns.
Vaccination is a vital part of our overall protection against this virus. That is why it is important to support people – perhaps especially young people – to make informed choices that they feel comfortable with.
In addition to the CMO advice on 12-15 year olds, we have received this morning the final JCVI advice on a vaccine booster programme.
This is in addition to the third doses already being offered to people who were severely immunosuppressed or immunocompromised at the time of their first or second vaccination.
I can confirm that the Scottish Government is also accepting this advice, and again we have adequate supplies to move ahead with this.
The booster programme is intended to prolong the protection that vaccines provide against severe COVID illness.
It will run alongside our biggest ever flu vaccine programme – since, of course, both of these programmes are important for individual and for public health. Wherever possible, eligible people will be offered COVID and flu vaccines together.
Booster vaccines will be offered to all adults over 50; to frontline health and care workers; and to younger adults with certain health conditions that put them at higher risk; and to adult household contacts of people with suppressed immune systems. The JCVI has also advised that there should be an interval of at least six months between a second dose and a booster dose.
So let me now give a broad outline of the order in which we will now move to implement the booster programme. And of course we will set out more details shortly.
Frontline health and social care workers will be able to book their booster appointment online through NHS Inform from Monday 20 September – so that again is Monday coming.
Also from next week, residents in care homes for older people will be offered both flu and COVID booster vaccines.
Adults aged 70 or over, and everyone aged over 16 on the highest risk list will be contacted very shortly, either by letter or by their GP.
Other eligible groups – that’s all adults over 50, all those 16 to 49 with underlying health conditions, adult carers, unpaid and young carers, and adult household contacts of people who are immunosuppressed – will be able to book online from October.
These two announcements today, Presiding Officer, represent a very significant, and a very welcome, extension of the vaccine programme – and will help us considerably in our ongoing efforts against this virus.
So – to anyone eligible for vaccination – please do take up the opportunity.
The final point about vaccination I want to touch on very briefly is certification for certain venues – which, of course, Parliament approved in principle last week.
We are now working with businesses, events organisers and sports governing bodies to finalise the detail of the regulations and sector-specific guidance.
COVID certification has of course already been introduced in many countries across Europe. Indeed, many of them have already gone much further than we are proposing.
We know that this is not a magic wand – but we do believe that as part of a package of measures, it can help reduce transmission while keeping our economy and our society open, which is of course what all of us want to see.
Presiding Officer, I will close by emphasising again the key things all of us can do to help, and to ensure that we keep infections on a downward track.
Firstly, as I’ve already been talking extensively about – please get vaccinated if you are eligible and you haven’t yet done so.
Secondly, please continue to test yourself regularly with lateral flow devices. You can order these through NHS inform or collect them from a local test site or pharmacy.
And if you test positive, or you are identified as a close contact, or if you have symptoms of COVID, please self-isolate, and book a PCR test.
And thirdly and finally, please continue to comply with the mitigations still in place.
Please wear face coverings in indoor public places, such as shops, public transport and when moving about in hospitality settings.
Think carefully about the number of contacts you are having – and perhaps reduce any that are not strictly necessary.
Meet outdoors as much as possible.
Indoors, open windows if you can.
And, although it’s not the law anymore, try to keep a safe distance from people in other households – especially when you are indoors.
And remember to continue to wash your hands and surfaces thoroughly.
All of us this – as we can see in the most recent data – really does make a difference. So please stick with it and let’s get cases down even further.
Thank you, Presiding Officer.
Teaching union the EIS has welcomed the decision by the UK’s Chief Medical Officers (CMOs) that young people aged between 12 and 15 should be offered a COVID vaccination.
Infection rates have increased substantially in recent weeks, and we have seen record levels of both pupil and staff Covid related absences particularly amongst young people, as schools have returned. This is having a serious impact on education provision and has been a cause for concern for teachers and other school staff.
EIS General Secretary Larry Flanagan said, “The EIS welcomes this decision by the CMOs as the latest step in the battle against Coronavirus. Offering the vaccine to young people in the 12 to 15 age group will make secondary schools safer by reducing the risk of the virus spreading through school communities and will help reduce the level of disruption to education.
“Whilst we know that young people are less likely to become hospitalised through COVID, offering the vaccine will offer important additional protection against the virus.”
Mr Flanagan added, “In the few short weeks since our schools returned after the summer, we have already seen significant outbreaks in some school communities. This has led to an increase in enforced absences from school, with record numbers of students and staff forced to stay at home due to Coronavirus.
“Rolling out the availability of the vaccines to a wider group of young people will reduce the risk of further outbreaks linked to schools and help ensure that education provision can continue on as normal a basis as possible.”
School Safety Mitigations Extended
Safety mitigations to keep children, young people and staff safe in schools will be extended until at least the October holidays.
Education Secretary Shirley-Anne Somerville confirmed that all current mitigations, including the use of face coverings by pupils in secondary school classrooms, will still be required to help keep schools as safe as possible.
In addition, updated guidance will be provided in the information letters that schools are asked to send to staff and the parents of primary and secondary pupils when they are in low risk contact with positive cases in schools.
These will now include a strengthened recommendation to take a lateral flow test before returning to school. This is in addition to current advice for staff and secondary pupils to take a lateral flow test twice a week, with a few days apart, and record the result before returning to the classroom.
There will be a continued requirement for staff to keep at least a metre distance from each other and from children and young people when they are at schools.
Revised guidance to reflect these changes will be published as soon as possible.
Ms Somerville said: “Throughout this coronavirus pandemic, the safety of school pupils and staff has been my top priority. Every decision is underpinned by our determination to keep children and young people in schools when is safe to do so.
“In light of the latest data and evidence, we have decided to extend the period for these mitigations to remain in place. This decision has been informed by expert medical advice and will be kept under close review to ensure it remains appropriate.
“We owe a debt of gratitude to our young people, for their continued compliance with the public health measures that keep us all safe. I promise that if we can remove the restrictions sooner, we will. For the moment though, we consider this an important protection for them, and for others in the school.”
Scotland will host the 16th Conference of Youth (COY16), the UN’s official youth event for COP26.
The Conference of Youth is an essential part of the COP calendar, helping to prepare young people for their participation in COP. It gives young people a voice in the climate negotiations, while providing delegates from over 140 countries the chance to meet, share experiences and build skills.
The conference will result in the Statement of Youth, which is presented on behalf of young people at every COP, setting out their hopes and expectations for the climate negotiations.
Five young people from Scotland will be selected to represent the country as delegates and contribute to the Statement.
This event, which runs from 28-31 October in Glasgow, will be funded by the Scottish Government and delivered by YOUNGO – the youth constituency of the United Nations Framework Convention on Climate Change (UNFCCC).
The First Minister said:“Young people have been among the strongest voices calling for urgent global action to address climate change. They have been an inspiration and I am proud that we are playing a role in giving them a platform at the heart of COP26 in Glasgow.
“The Conference of Youth will represent young people from 140 countries around the world, including here in Scotland. It is designed by young people, for young people, so they can set out their asks of world leaders ahead of the climate negotiations.
“Through this support we are ensuring that Scotland will play its part in securing an ambitious and deliverable global deal at COP26.
“I look forward to welcoming COY16 to Glasgow and engaging with them on our shared endeavour to tackle the climate crisis, with young people at the heart of our commitment to a just transition.”
Heeta Lakhani, YOUNGO Focal Point (Global South) and Marie-Claire Graf YOUNGO Focal Point (Global North) said:“The support of the Scottish Government is proof of legitimate youth inclusion and participatory governance in the lead up to the 26th UN Climate Conference.
“The official UN Climate Change Youth Constituency, YOUNGO, and the young climate advocates globally welcome this partnership not only to deliver COY16 and our presence in COP, but also as a sign that we are heard and involved.
“The commitment and backing of the Scottish Government will surely be part of the climate movement’s history. In these challenging times, it is important that we work on shared goals together. Let’s unify for change!”
Move follows unanimous advice to ministers from the four UK Chief Medical Officers
Parental consent will be sought prior to vaccination
People aged 12 to 15 in England will be offered one dose of the Pfizer/BioNTech COVID-19 vaccine, following advice from the four UK Chief Medical Officers (CMOs), the Health and Social Care Secretary has announced. The Scottish Government is expected to make an announcement later today.
In line with the recommendation of the independent Joint Committee on Vaccination and Immunisation (JCVI), the government sought the views of the four UK CMOs on the wider issues that are relevant to the health of children.
The UK Government has accepted the advice of the four UK CMOs and the NHS is preparing to deliver a schools-based vaccination programme, which is the successful model used for vaccinations including for HPV and Diphtheria, Tetanus and Polio (DTP), supported by GPs and community pharmacies. Invitations for vaccination will begin next week.
Parental, guardian or carer consent will be sought by vaccination healthcare staff prior to vaccination in line with existing school vaccination programmes.
Healthy school-aged children aged 12 to 15 will primarily receive their COVID-19 vaccination in their school with alternative provision for those who are home schooled, in secure services or specialist mental health settings.
Health and Social Care Secretary, Sajid Javid said: “I have accepted the recommendation from the Chief Medical Officers to expand vaccination to those aged 12 to 15 – protecting young people from catching COVID-19, reducing transmission in schools and keeping pupils in the classroom.
“I am very grateful for the expert advice I have received from the Joint Committee on Vaccination and Immunisation and UK Chief Medical Officers.
“Our outstanding NHS stands ready to move forward with rolling out the vaccine to this group with the same sense of urgency we’ve had at every point in our vaccination programme.”
THE CHIEF MEDICAL OFFICERS’ LETTER READS:
To: Sajid Javid MP, Secretary of State for Health and Social Care, HM Government Eluned Morgan AS/MS, Minister for Health and Social Services, Welsh Government Humza Yousaf MSP, Cabinet Secretary for Health and Social Care, Scottish Government Robin Swann MLA, Minister of Health Northern Ireland Executive
13 September 2021
Dear Secretary of State, Cabinet Secretary and ministers,
Universal vaccination of children and young people aged 12 to 15 years against COVID-19
Background
The Joint Committee on Vaccination and Immunisation (JCVI) in their advice to you on 2 September 2021 on this subject said: ‘Overall, the committee is of the opinion that the benefits from vaccination are marginally greater than the potential known harms… but acknowledges that there is considerable uncertainty regarding the magnitude of the potential harms.
The margin of benefit, based primarily on a health perspective, is considered too small to support advice on a universal programme of vaccination of otherwise healthy 12 to 15-year-old children at this time…. JCVI is constituted with expertise to allow consideration of the health benefits and risks of vaccination and it is not within its remit to incorporate in-depth considerations on wider societal impacts, including educational benefits. The government may wish to seek further views on the wider societal and educational impacts from the Chief Medical Officers of the 4 nations, with representation from JCVI in these subsequent discussions.‘
You accepted this recommendation from JCVI, and wrote to us on 2 September 2021 stating “We agree with the approach suggested by JCVI, and so we are writing to request that you take forward work (drawing on experts as you see fit) to consider the matter from a broader perspective, as suggested by the JCVI.”
In doing so we have been fortunate to have been informed by the independent expertise of leaders of the clinical and public health profession from across the UK. This has included Presidents and Chairs or their representative of:
Royal College of Paediatrics and Child Health
Royal College of General Practice
Royal College of Psychiatry
Faculty of Public Health
Academy of Medical Royal Colleges representing all the other Royal Colleges and Faculties
Association of Directors of Public Health
Regional Directors of Public Health
national public health specialists
experts in data and modelling
We are very grateful to them for taking considerable time and effort to consult their own colleagues in all 4 nations at short notice to get a comprehensive view of the balance of informed medical opinion and experience across the UK.
The UK’s independent regulator of medicines and vaccines the Medicines and Healthcare products Regulatory Agency (MHRA) is in law the appropriate body to determine whether, based on risk-benefit grounds, a vaccine is safe and effective to use and so grant a licence. They have done so for children and young people aged over 12 years for two vaccines against COVID-19, those manufactured by Pfizer and Moderna. Their assessment is that benefits exceed risks on an individual basis. We take their independent opinion as read. The MHRA position on mRNA vaccines is similar to the relevant regulatory approvals granted in the same age groups in multiple other jurisdictions including but not limited to the USA, the European Union, and Canada.
The independent JCVI is the proper body to give advice on how to deploy a vaccine which has a prior favourable risk-benefit decision and authorisation from MHRA including whether it has a sufficiently large benefit to be worth deploying on a larger, population scale. Like MHRA they consider the benefits of vaccination in this age group exceed the risks (i.e. it is better to be vaccinated than not vaccinated in this age group).
They balanced the risk of COVID-19 against the risks of vaccination, including myocarditis. When forming its advice, the JCVI considered vaccine use according to clinical risk groups, thus identifying different groups according to their potential to benefit from vaccination.
For 12 to 15 year olds who do not have underlying health conditions that place them at higher risk from severe COVID-19, the JCVI considered that the size of both the risk and the benefit are at an individual level very small, and the overall advantage for vaccination, whilst present, is therefore not sufficiently large to recommend universal vaccination on their usual criteria.
They deemed the extent to which vaccination might mitigate the impacts of COVID-19 on education was beyond the usual remit of the JCVI. They recognised however that given the substantial scale of the impact of COVID-19 on all children and young people, which goes beyond normal clinical benefit and risk, wider issues could, exceptionally, be relevant hence their suggestion to consult UK CMOs.
The JCVI have already recommended that children and young people aged 12 to 17 with specific underlying health conditions, and children and young people who are aged 12 years and over who are household contacts of persons who are immunocompromised are offered two doses of a vaccine, normally Pfizer BioNTech BNT162b2. They have recommended all young people 16 to 17 are offered an initial first dose of vaccine.
The UK has benefited from having data from the USA, Canada and Israel, which have already offered vaccines universally to children and young people aged 12 to 15.
The UK CMOs start from the position that the MHRA and JCVI set out on individual benefit-risk calculations for this age group, and have not revisited this. We accept that at an individual level benefit exceeds risk but this advantage is small, and we have taken the JCVI figures as the UK current position on this question.
The Chair of the JCVI Prof. Lim has been a member of our group to ensure that there is no duplication of effort or conflict between the views of UK CMOs and the JCVI. We have been fortunate to have been joined also by the lead Deputy Chief Medical Officers for vaccines Prof. Van Tam (England), Prof. Steedman (Scotland) and Dr. Chada (Northern Ireland) and the DHSC Chief Scientific Adviser, Prof. Chappell. The final advice is that of the Chief Medical Officers, but informed by independent senior clinical and public health input from across the UK.
UK CMOs have decided in their ToR that we will only consider benefits and disbenefits to those aged 12 to 15 from vaccinating this age group, including indirect benefits. Whilst there may be benefits to other age groups, these have not been considered in our advice below.
Issues of vaccine supply were not factors considered in decision making.
The UK CMOs are aware of the extensive range of non-clinical views but this UK CMOs advice is purely clinical and public health derived and has not taken issues outside their clinical and public health remit into account. There is a subsequent political process where wider societal issues may be considered by ministers in deciding how they respond to this advice.
Advice
All drugs, vaccines and surgical procedures have both risks and benefits. If the risks exceed benefits the drug, vaccine or procedure should not be advised, and a drug or vaccine will not be authorised by MHRA. If benefits exceed risks then medical practitioners may advise the drug or vaccine, but the strength of their advice will depend on the degree of benefit over risk.
At an individual level, the view of the MHRA, the JCVI and international regulators is that there is an advantage to someone aged 12 to 15 of being vaccinated over being unvaccinated. The COVID-19 Delta variant is highly infectious and very common, so the great majority of the unvaccinated will get COVID-19. In those aged 12 to 15, COVID-19 rarely, but occasionally, leads to serious illness, hospitalisation and even less commonly death. The risks of vaccination (mainly myocarditis) are also very rare. The absolute advantage to being vaccinated in this age group is therefore small (‘marginal’) in the view of the JCVI. On its own the view of the JCVI is that this advantage, whilst present, is insufficient to justify a universal offer in this age group. Accepting this advice, UK CMOs looked at wider public health benefits and risks of universal vaccination in this age group to determine if this shifts the risk-benefit either way.
Of these, the most important in this age group was impact on education. UK CMOs also considered impact on mental health and operational issues such as any possible negative impact on other vaccine programmes, noting that influenza vaccination and other immunisations of children and young people are well-established, important, and that the annual flu vaccine deployment programme commences imminently.
The UK CMOs, in common with the clinical and wider public health community, consider education one of the most important drivers of improved public health and mental health, and have laid this out in their advice to parents and teachers in a previous joint statement. Evidence from clinical and public health colleagues, general practice, child health and mental health consistently makes clear the massive impact that absent, or disrupted, face-to-face education has had on the welfare and mental health of many children and young people. This is despite remarkable efforts by parents and teachers to maintain education in the face of disruption.
The negative impact has been especially great in areas of relative deprivation which have been particularly badly affected by COVID-19. The effects of missed or disrupted education are even more apparent and enduring in these areas. The effects of disrupted education, or uncertainty, on mental health are well recognised. There can be lifelong effects on health if extended disruption to education leads to reduced life chances.
Whilst full closures of schools due to lockdowns is much less likely to be necessary in the next stages of the COVID-19 epidemic, UK CMOs expect the epidemic to continue to be prolonged and unpredictable. Local surges of infection, including in schools, should be anticipated for some time. Where they occur, they are likely to be disruptive.
Every effort should be taken to minimise school disruption in policy decisions and local actions. Vaccination, if deployed, should only be seen as an adjunct to other actions to maintain children and young people in secondary school and minimise further education disruption and therefore medium and longer term public health harm.
On balance however, UK CMOs judge that it is likely vaccination will help reduce transmission of COVID-19 in schools which are attended by children and young people aged 12 to 15 years. COVID-19 is a disease which can be very effectively transmitted by mass spreading events, especially with Delta variant. Having a significant proportion of pupils vaccinated is likely to reduce the probability of such events which are likely to cause local outbreaks in, or associated with, schools. They will also reduce the chance an individual child gets COVID-19. This means vaccination is likely to reduce (but not eliminate) education disruption.
Set against this there are operational risks that COVID-19 vaccination could interfere with other, important, vaccination programmes in schools including flu vaccines.
Overall however the view of the UK CMOs is that the additional likely benefits of reducing educational disruption, and the consequent reduction in public health harm from educational disruption, on balance provide sufficient extra advantage in addition to the marginal advantage at an individual level identified by the JCVI to recommend in favour of vaccinating this group.
They therefore recommend on public health grounds that ministers extend the offer of universal vaccination with a first dose of Pfizer-BioNTech COVID-19 vaccine to all children and young people aged 12 to 15 not already covered by existing JCVI advice.
If ministers accept this advice, UK CMOs would want the JCVI to give a view on whether, and what, second doses to give to children and young people aged 12 to 15 once more data on second doses in this age group has accrued internationally. This will not be before the spring term.
In recommending this to ministers, UK CMOs recognise that the overwhelming benefits of vaccination for adults, where risk-benefit is very strongly in favour of vaccination for almost all groups, are not as clear-cut for children and young people aged 12 to 15. Children, young people and their parents will need to understand potential benefits, potential side effects and the balance between them.
If ministers accept this advice, issues of consent need to take this much more balanced risk-benefit into account. UK CMOs recommend that the Royal Colleges and other professional groups are consulted in how best to present the risk-benefit decisions in a way that is accessible to children and young people as well as their parents. A child-centred approach to communication and deployment of the vaccine should be the primary objective.
If ministers accept this advice, it is essential that children and young people aged 12 to 15 and their parents are supported in their decisions, whatever decisions they take, and are not stigmatised either for accepting, or not accepting, the vaccination offer. Individual choice should be respected.
Chief Medical Officer for England Prof. Christopher Whitty
Chief Medical Officer for Northern Ireland Sir Michael McBride
Chief Medical Officer for Scotland Dr. Gregor Smith
Chief Medical Officer for Wales Dr. Frank Atherton
Over four in five adults across the UK have received both COVID-19 vaccine doses, with over half of all 16 and 17 year olds coming forward for their first jab.
However COVID numbers continue to rise across the UK. 28,856 new cases were reported yesterday, with 4241 of these in Scotland. The daily Scottish figure is likely to be considerably higher due to an IT problem.
Responding to the advice from the Chief Medical Officers regarding the vaccination of all 12-15 year olds, Bruce Adamson, the Children and Young People’s Commissioner Scotland, said: “We welcome the advice to offer the vaccine to children between the age of 12 and 15. It is important to give them that choice.
“Children and young people have a right to the best possible health, that’s not just about protection from the Covid virus itself, but also the impact on their mental health due to isolation and other factors. The pandemic has impacted their right to education, their right to play, their right to see wider family and friends which is so essential to their development. Their education has been disrupted with two long periods of school closures.
“It is important that children are supported to make informed decisions about their own health. Children of this age group have told me over the last few months that they are in favour of having the choice to be vaccinated. That is not to say that all of them had made a decision about whether they would get a vaccine, but they wanted the option to be available to them. Of course, there have been some children who are concerned about vaccination, or who told me about parental concerns. It is important that there is no stigma attached to the choices that children make about vaccination.
“It is essential that this advice is communicated directly to 12 to 15 year olds in a child-friendly way so they can understand why they are now being offered the vaccine, and can have any questions they might have answered in a way they can understand. Children have the right to access appropriate information on decisions affecting them.
“Parents and carers will play an important role in supporting the decision-making around whether a child chooses to get vaccinated so it is important that they have all of the necessary information to support that choice.”
Stocks of personal protective equipment (PPE) are to be donated to Africa to aid their response to the COVID-19 pandemic.
The PPE equipment, worth £11.2 million, will be distributed by Kids Operating Room (KidsOR), a Scottish-based global health charity.
This distribution will be supported by £250,000 from the Scottish Government, which will fund the transport of 25 shipping containers of material to Malawi, Rwanda and Zambia.
KidsOR raised a further £1 million to support the transport of the PPE from the Wood Foundation, Pula Limited, Postcode Trust and Delta Philanthropies.
The supplies include masks, goggles, and visors and the shipment, made available through the NHS Scotland Global Citizenship Programme, is due to arrive in partner countries in late September.
International Development Minister Jenny Gilruth said: “COVID-19 knows no borders. I am pleased that the Scottish Government has been able to support this assistance to Malawi, Rwanda and Zambia – particularly as they look to plan for an expected fourth wave of COVID-19 in the coming months.
“This contribution builds on our recent supply of oxygen concentrators and ventilators, and we hope it will go some way to easing the current stress on health services.
“As the global pandemic continues, we firmly believe this is precisely the moment that Governments across the world should be stepping up to help those most in need.
“This donation underlines that the Scottish Government remains fully committed to playing our part in tackling the shared global challenge that the pandemic represents. I would like to thank KidsOR for supporting us to make it possible to distribute this PPE equipment along with the recent supply of oxygen concentrators and ventilators.”
Chief Executive of NHS National Services Scotland (NSS) Mary Morgan said: “The battle to beat COVID is truly a global effort. We are pleased that PPE secured by NSS is being donated to help those who need it most in Africa.
“We will continue to work with partners to identify further opportunities to support countries and communities who need our help.”
Co-Founder of KidsOR Garreth Wood said: “I would like to thank our donors for stepping up to help support the distribution of so many millions of items of PPE that will prove vital for countries in Africa battling the ongoing COVID pandemic.”
